Press Kits

As a highly focused research-driven biopharmaceutical company, AbbVie takes on the toughest health challenges. But we do more than treat diseases - we aim to make a remarkable impact on people's lives. The AbbVie Press Kit is designed to provide journalists with a broad range of background information on our company. If you are a member of the news media and have questions or need additional information, please contact our Communications Team.

Blood Cancer Press Kit

The words “you have cancer” are life-changing for everyone impacted by a new diagnosis. AbbVie understands this, and that is why we have joined forces with leading global patient advocates to increase awareness about blood cancers.

Together with U.S. News and World Report we break down the basics of cancers that originate in the blood.

In the first episode of our ongoing “Blood Cancer, Explained” video series, we were joined by our partners from the Leukemia & Lymphoma Society (LLS) and Advanced Practitioner Society for...

In the second episode of our ongoing “Blood Cancer, Explained” video series, we were joined by advocacy partners from the CLL Society and Lymphoma Research Foundation (LRF) to discuss the...

Advocacy organizations like the Lymphoma Coalition (LC) and the Leukemia and Lymphoma Society (LLS) serve as a voice for the blood cancer patient community. In episode three of our “Blood...

In the fourth installment of our ongoing “Blood Cancer, Explained” video series, we were joined by our global advocacy partner Acute Leukemia Advocates Network (ALAN) to discuss the complexity...

On June 24, 2022, AbbVie shared findings from the newly launched Emotional Impact Report, a survey of more than 300 chronic lymphocytic leukemia (CLL) patients, caregivers and healthcare providers...

100+ unique blood cancers exist and most fall under three main types: leukemia, lymphoma and myeloma. Learn more

An estimated 1.2 million blood cancer cases occur annually worldwide.

Subscribe to email alerts

Stay up to date on recent news, articles, and more by subscribing to email alerts for one or more of our news topics.

Learn more



The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?